See more : Valora Holding AG (VALN.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Miwon Commercial Co., Ltd. (002840.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Miwon Commercial Co., Ltd., a leading company in the Chemicals industry within the Basic Materials sector.
- Reliance Naval and Engineering Limited (RNAVAL.NS) Income Statement Analysis – Financial Results
- Farm Pride Foods Limited (FRM.AX) Income Statement Analysis – Financial Results
- Standard Lithium Ltd. (SLI.V) Income Statement Analysis – Financial Results
- Hargreaves Lansdown plc (HRGLY) Income Statement Analysis – Financial Results
- On Track Innovations Ltd. (OTIVF) Income Statement Analysis – Financial Results
Miwon Commercial Co., Ltd. (002840.KS)
About Miwon Commercial Co., Ltd.
Miwon Commercial Co., Ltd. manufactures and markets various chemical products in South Korea and internationally. The company offers personal care ingredients, including anionic, cationic, nonionic, and amphoteric surfactants; hair fixative and conditioning polymers; styling resins; household surfactants, plasticizers, and UV stabilizers; and cosmeceutical active ingredients. It also provides electronic chemicals, such as photo active compounds for micro-patterning of semiconductor circuits and thin film transistors in LCDs; polymer acryl binders and novolak resins for use in LCD and plasma displays, and positive photoresist for LCDs and semiconductors; and functional chemicals and additives for use in positive and negative photoresist for LCD, as well as in process chemicals, such as strippers. In addition, the company offers functional resins used as raw materials for PCBs, components of electronic equipment, materials for high-functional polycarbonate, and high refractive monomers used in manufacturing optical films for displays. Further, it provides antioxidants, including amine, phenol, phosphorus, and sulfur, as well as UV stabilizers that include benzophenone, benzotriazole, nickel quenchers, and HALS; and thiourethane lens monomers. Miwon Commercial Co., Ltd. was founded in 1959 and is headquartered in Anyang, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 421.37B | 438.19B | 359.79B | 294.98B | 249.99B | 328.65B | 318.66B | 301.74B | 239.44B | 247.22B | 235.23B | 182.38B | 139.68B | 151.06B | 190.84B | 66.82B | 193.19B |
| Cost of Revenue | 320.84B | 330.05B | 275.11B | 226.92B | 195.14B | 275.72B | 279.96B | 250.96B | 200.11B | 209.90B | 195.66B | 148.60B | 114.15B | 123.20B | 151.10B | 54.52B | 162.46B |
| Gross Profit | 100.53B | 108.14B | 84.68B | 68.06B | 54.85B | 52.93B | 38.70B | 50.78B | 39.33B | 37.31B | 39.57B | 33.77B | 25.53B | 27.86B | 39.74B | 12.30B | 30.73B |
| Gross Profit Ratio | 23.86% | 24.68% | 23.54% | 23.07% | 21.94% | 16.11% | 12.14% | 16.83% | 16.43% | 15.09% | 16.82% | 18.52% | 18.28% | 18.44% | 20.83% | 18.40% | 15.91% |
| Research & Development | 12.07B | 10.35B | 9.16B | 8.57B | 8.11B | 7.87B | 7.07B | 8.99B | 7.69B | 7.48B | 6.99B | 5.48B | 4.36B | 4.39B | 4.19B | 1.02B | 4.98B |
| General & Administrative | 1.13B | 727.79M | 540.52M | 585.34M | 938.00M | 876.47M | 1.01B | 1.02B | 785.02M | 779.10M | 775.69M | 540.36M | 553.92M | 708.67M | 925.97M | 419.72M | 1.07B |
| Selling & Marketing | 9.74B | 9.28B | 7.94B | 7.02B | 5.76B | 8.28B | 10.28B | 9.22B | 5.98B | 6.28B | 6.03B | 4.00B | 2.92B | 4.53B | 9.23B | 2.68B | 8.49B |
| SG&A | 21.54B | 10.01B | 8.49B | 7.61B | 6.70B | 9.15B | 11.29B | 10.24B | 6.76B | 7.06B | 6.81B | 4.54B | 3.47B | 5.24B | 10.15B | 3.10B | 9.55B |
| Other Expenses | 0.00 | 10.76B | 9.89B | 9.00B | 7.78B | 8.73B | 564.05M | 3.38B | 1.20B | 1.25B | 1.27B | 2.09B | 98.07M | 403.39M | 1.06B | 287.54M | 270.91M |
| Operating Expenses | 33.29B | 31.13B | 27.53B | 25.18B | 22.59B | 25.76B | 27.70B | 28.00B | 20.88B | 19.59B | 21.44B | 14.64B | 11.30B | 14.03B | 20.62B | 5.73B | 20.37B |
| Cost & Expenses | 354.13B | 361.17B | 302.64B | 252.10B | 217.73B | 301.48B | 307.66B | 278.96B | 220.99B | 229.49B | 217.10B | 163.25B | 125.45B | 137.23B | 171.71B | 60.25B | 182.83B |
| Interest Income | 1.06B | 215.57M | 214.33M | 170.89M | 223.01M | 274.02M | 197.92M | 194.29M | 166.14M | 165.55M | 140.57M | 118.52M | 0.00 | 291.68M | 300.89M | 338.54M | 376.79M |
| Interest Expense | 2.67M | 77.11M | 4.36M | 114.12M | 42.67M | 511.74M | 525.45M | 702.13M | 965.63M | 1.54B | 1.63B | 1.68B | 0.00 | 1.05B | 1.33B | 1.32B | 1.08B |
| Depreciation & Amortization | 30.52B | 27.38B | 24.10B | 18.28B | 13.04B | 14.73B | 21.30B | 15.33B | 13.81B | 13.91B | 12.17B | 8.50B | 6.72B | 9.38B | 9.11B | 3.16B | 8.85B |
| EBITDA | 102.63B | 107.78B | 87.66B | 75.49B | 48.55B | 41.29B | 52.91B | 41.69B | 32.26B | 31.64B | 30.30B | 32.64B | 25.56B | 24.87B | 30.93B | 8.97B | 21.95B |
| EBITDA Ratio | 24.36% | 26.35% | 26.47% | 27.32% | 21.65% | 12.61% | 11.61% | 14.66% | 14.83% | 13.72% | 13.93% | 17.90% | 15.30% | 16.02% | 16.49% | 11.07% | 11.36% |
| Operating Income | 67.24B | 77.02B | 57.15B | 62.31B | 32.26B | 27.17B | 11.00B | 22.79B | 18.45B | 17.73B | 18.13B | 19.13B | 17.56B | 13.83B | 19.13B | 6.57B | 10.35B |
| Operating Income Ratio | 15.96% | 17.58% | 15.89% | 21.12% | 12.90% | 8.27% | 3.45% | 7.55% | 7.71% | 7.17% | 7.71% | 10.49% | 12.57% | 9.16% | 10.02% | 9.83% | 5.36% |
| Total Other Income/Expenses | 8.89B | 10.81B | 14.11B | 188.94M | 9.18B | -1.13B | 20.09B | 3.22B | 2.53B | -821.93M | -353.69M | -8.48B | -1.11B | 621.85M | 1.37B | -2.08B | 7.11B |
| Income Before Tax | 76.13B | 87.83B | 71.27B | 62.50B | 41.44B | 26.04B | 31.08B | 32.30B | 21.35B | 17.22B | 18.91B | 20.60B | 16.44B | 14.45B | 20.49B | 4.49B | 17.46B |
| Income Before Tax Ratio | 18.07% | 20.04% | 19.81% | 21.19% | 16.58% | 7.92% | 9.75% | 10.70% | 8.92% | 6.96% | 8.04% | 11.30% | 11.77% | 9.57% | 10.74% | 6.72% | 9.04% |
| Income Tax Expense | 15.12B | 15.61B | 13.52B | 10.65B | 10.32B | 1.83B | 4.46B | 5.93B | 4.38B | 5.54B | 2.82B | 3.04B | 2.95B | 2.91B | 3.19B | 656.26M | 3.73B |
| Net Income | 61.02B | 72.22B | 57.74B | 51.85B | 31.12B | 21.53B | 27.22B | 21.86B | 14.29B | 9.83B | 13.72B | 17.57B | 13.49B | 18.92B | 17.32B | 6.41B | 13.73B |
| Net Income Ratio | 14.48% | 16.48% | 16.05% | 17.58% | 12.45% | 6.55% | 8.54% | 7.24% | 5.97% | 3.98% | 5.83% | 9.63% | 9.66% | 12.52% | 9.07% | 9.59% | 7.11% |
| EPS | 12.77K | 14.75K | 11.64K | 10.37K | 6.16K | 660.61 | 5.00K | 3.89K | 2.52K | 1.74K | 2.42K | 3.16K | 2.41K | 2.21K | 1.94K | 486.92 | 995.28 |
| EPS Diluted | 12.77K | 14.75K | 11.64K | 10.37K | 6.16K | 660.61 | 5.00K | 3.89K | 2.52K | 1.74K | 2.42K | 3.16K | 2.41K | 2.21K | 1.94K | 486.92 | 995.28 |
| Weighted Avg Shares Out | 4.78M | 4.90M | 4.96M | 5.00M | 5.05M | 32.59M | 5.44M | 5.62M | 5.67M | 5.64M | 5.67M | 5.76M | 5.60M | 8.56M | 8.94M | 13.16M | 13.80M |
| Weighted Avg Shares Out (Dil) | 4.78M | 4.90M | 4.96M | 5.00M | 5.05M | 32.59M | 5.44M | 5.62M | 5.67M | 5.64M | 5.67M | 5.76M | 5.60M | 8.56M | 8.94M | 13.16M | 13.80M |
Source: https://incomestatements.info
Category: Stock Reports